We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Phthisis Diagnostics Announces First International Distribution Agreement in Asia
Product News

Phthisis Diagnostics Announces First International Distribution Agreement in Asia

Phthisis Diagnostics Announces First International Distribution Agreement in Asia
Product News

Phthisis Diagnostics Announces First International Distribution Agreement in Asia


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Phthisis Diagnostics Announces First International Distribution Agreement in Asia"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Phthisis Diagnostics, Inc. has announced the signing of a distribution agreement for international sales in India, its first in the Asian market.  The contract follows the company’s first international distribution agreement announced in May for sales throughout Latin America.

Genetix Biotech Asia, Ltd., located in New Delhi represents world leading companies that supply molecular biology, genomics, proteomics, immunology, and cell culture laboratories.

Genetix will handle the entire Phthisis Diagnostics product line, including those items being introduced to the market now and those in development. Phthisis currently offers the E-Sphere® Simple NA Kit for easily and quickly extracting nucleic acids from various types of samples.  Future products will include molecular diagnostics for parasites and fungi, as well as molecular standards for improved laboratory quality control.

Phthisis Diagnostics President and Chief Science Officer Crystal Icenhour, PhD, commented, “We are excited to extend our marketing into Asia with this agreement and are looking forward to continuing to expand our distribution network.”

Advertisement